Bristol Myers Squibb announced that it invested $400 million to build a sterile drug product (SDP) facility in Dublin, Ireland. This Cruiserath facility will support the manufacturing and supply of existing medicines and serve as a launch excellence facility for pipeline assets. It marks the first European SDP facility for biologics manufacturing at Bristol Myers…
AbbVie president and COO to move into corner office
AbbVie (NYSE: ABBV) recently announced that its board of directors has decided to promote the company’s president and COO Robert A. Michael into the corner office. Michael will succeed Richard A. Gonzalez, who is retiring as CEO on July 1. Gonzalez will stay as executive chair of AbbVie’s board. “On behalf of AbbVie’s board, I…
Amgen opens AI-enabled Ohio biomanufacturing facility
Earlier this year, NVIDIA and Amgen revealed plans to analyze one of the world’s largest human datasets using AI models trained on an NVIDIA DGX SuperPOD in Iceland. Now, Amgen is signaling its continued commitment to cutting-edge tech with a ribbon cutting for an advanced biomanufacturing facility in New Albany, Ohio. Known as Amgen Ohio,…
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
MES for Flexible, Paperless Pharmaceutical Production
All companies in the pharmaceutical industry are under pressure for time, quality, compliance, and innovation. These pressures create imperatives to be both paperless and flexible to protect profitability. The stresses and imperatives apply to small-molecule pharmaceuticals, active ingredients (API), contract drug manufacturers (CDMOs), large-molecule biotechnology, and gene and cell therapy makers. Fortunately, a manufacturing execution…
Pave the way to high productivity with continuous manufacturing for pharma
Continuous manufacturing in the pharmaceutical industry is increasing as more manufacturers realize the benefits of the technology. But no two manufacturers are the same, which is why support from the Siemens Smart Manufacturing Solution for Pharmaceuticals helps advance the strategies of your operations. Learn how a pharmaceutical product that previously took 1-2 months in production…
Takeda wins approval for eosinophilic esophagitis drug Eohilia
Takeda announced this week that it received FDA approval for its Eohilia (budesonide oral suspension) therapy. This makes Eohilia the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE). Takeda plans to offer it in 2 mg/10 mL convenient, single-dose stick packs by the end of February. Eohilia, a…
Catalent cuts 300 jobs ahead of acquisition by Novo Holdings
Catalent said this week that it reduced its headcount by approximately 300 employees as part of a restructuring effort. The company confirmed the workforce reduction in its 10-Q quarterly report, filed on Feb. 14. This also coincides with preparations for an acquisition as Novo Holdings agreed to buy the leading pharmaceutical CDMO for $16.5 billion…
AbbVie is expanding its Singapore biologics plant
AbbVie (NYSE: ABBV) recently announced that it will spend $223 million to expand its Singapore biologics manufacturing facility. Construction will commence immediately, with the facilities coming online in 2026. The added facilities will create 100 new jobs at the plant, boosting total employment to more than 500 positions in manufacturing, quality assurance, supply chain, engineering…
Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
Imagine scaling a mountain only to later lose digits or an entire hand to the unforgiving ravages of frostbite. For climbers, explorers, adventurous backcountry skiers, and even those caught in unexpected winter storms, severe cold exposure carries a devastating risk — amputation. Today, thanks to a potentially landmark FDA approval, the prospect of losing one’s…